Individual Patient Data from the Pivotal Randomized Controlled Trials of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation (COMBINE AF): Design and Rationale
Anthony Carnicelli, Hwanhee Hong, Robert P. Giugliano, Stuart J. Connolly, John W. Eikelboom, Manesh R. Patel, Lars Wallentin, David A. Morrow, Daniel Wojdyla, Kaiyuan Hua, Stefan H. Hohnloser, Jonas Oldgren, Christian T. Ruff, Jonathan P. Piccini, Renato D. Lópes, John H. Alexander, Christopher B. Granger
Topics & Concepts
MedicineWarfarinAtrial fibrillationRandomized controlled trialAspirinVitamin K antagonistStroke (engine)ApixabanClinical trialIntensive care medicineInternal medicineRivaroxabanCardiologyMechanical engineeringEngineeringAtrial Fibrillation Management and OutcomesIntracerebral and Subarachnoid Hemorrhage ResearchAcute Ischemic Stroke Management